Astra has agreed a deal that could be worth almost £4billion with a Chinese company to use AI in the production of new ...

On what seemed like an ordinary Thursday, an Air India Dreamliner carrying 242 people crashed near Ahmedabad—just 30 seconds ...

The collaboration will focus on identifying pre-clinical candidates for high-priority targets, including a small molecule ...

British drugmaker AstraZeneca unveiled on Friday an AI-assisted research partnership with Chinese counterpart CSPC ...

Entering the era of agentic AI will shift investment to agentic experiences, but keeping humans at the center of the customer ...

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured ...

AstraZeneca has signed a deal worth up to $5.2bn to work with a Chinese biotech company using AI to develop new treatments for chronic diseases.

The adoption of AI agents in healthcare is an essential strategy for institutions that seek efficiency, agility and smarter ...

A new article in the Journal of the American Medical Association said the FDA will implement AI into multiple processes.

AstraZeneca has signed an AI-led research agreement with China's CSPC Pharmaceutical Group worth up to $5.3 billion, which ...

The company focuses on specialty drugs and uses a combination of AI and human expertise to automate the process.